Both Amedisys Inc. (NASDAQ: AMED) and LHC Group Inc. (NASDAQ: LHCG) are Home Health Care agencies competing with each other. We will evaluate their institutional possession, profitability, danger, dividends, analyst recommendations, income, and valuation.
Earnings and Valuation
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Amedisys Inc. 1.66B 2. Forty-six 119.35M three.23 37.50
LHC Group Inc. 1.81B 1.92 sixty-three.57M 1. Seventy-seven sixty one.54
Demonstrates Amedisys Inc. And LHC Group Inc. The income per share (EPS), gross revenue, and valuation. LHC Group Inc. Seems to has lower income, however, better revenue compared to Amedisys Inc. When an enterprise has a decrease charge-to-income approach, it is more affordable than its counterpart presently. Amedisys Inc. It currently is more low priced than LHC Group Inc. because it’s buying and selling at a lower price-to-profits ratio.
Table 2 demonstrates the return on belongings, return on fairness, and internet margins of Amedisys Inc. And LHC Group Inc.
Net Margins Return on Equity Return on Assets
Amedisys Inc. 7.19% 14.Nine% nine.1%
LHC Group Inc. 3. Fifty one% 5.9% three.Eight%
Volatility & Risk
Amedisys Inc.’s 1.35 beta shows that its volatility is 35.00% extra unstable than that of Standard & Poor’s 500. Competitively, LHC Group Inc.’s 11.00% volatility makes it much less risky than Standard & Poor’s 500 due to the 0.89 beta.
Amedisys Inc. Has a Current Ratio of 1.1 and a Quick Ratio of 1.1. Competitively, LHC Group Inc.’s Current Ratio is 1.6 and has a 1.6 Quick Ratio. LHC Group Inc.’s higher potential to pay brief and lengthy-time period duties than Amedisys Inc.
Ratings and Recommendations for Amedisys Inc. And LHC Group Inc. Can discover in the next desk.
Sell Ratings Hold Ratings Buy Rating Rating Score
Amedisys Inc. Zero 4 2 2.33
LHC Group Inc. Zero three 3 2.50
Amedisys Inc. Has a mean charge target of $130.83 and a 2.30% upside potential. On the opposite hand, LHC Group Inc.’s ability upside is five.29%, and its average fee target is $116.29. The outcomes furnished in advance show that LHC Group Inc. Seems more significant favorable than Amedisys Inc., primarily based on analyst perception.
Insider and Institutional Ownership
Amedisys Inc. And LHC Group Inc. have stocks held with institutional traders’ aid as follows: ninety-three % and 96%. 1.1% is Amedisys Inc.’s share held by using insiders. Insiders Competitively held 1.3% of LHC Group Inc. Stocks.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly, and YTD PerfoPerformanceoth pretenders.
Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Amedisys Inc. -four.Sixty three% -7.Seventy four% -nine.Seventy one% -1.6% 111.Fifty nine% 3.33%
LHC Group Inc. 0.Eleven% three.26% 5.01% eleven.Four% 78.78% 16.3%
For the past year, Amedisys Inc. Has weaker perf performance LHC Group Inc.
Amedisys, Inc., together with its subsidiaries, gives healthcare offerings in the United States. It operates via three segments: Home Health, Hospice, and Personal Care. The Home Health section offers more than a few offerings in the homes of individuals for the restoration of sufferers from surgical treatment, chronic incapacity, or terminal illness, in addition to prevents avoidable sanatorium readmissions via its professional nurses, physical and speech therapists, occupational therapists, and aides for its sufferers to complete their critical private obligations. The Hospice phase gives care that is designed to offer consolation and help for folks who are dealing with a terminal illness, together with a heart disorder, pulmonary disease, AlzheimerÂ’s, HIV/AIDS, and most cancers. The Personal Care phase offers help for sufferers with the activities of each day living. As of March 1, 2017, the corporation owned and operated 420 care facilities in 34 states. Amedisys, Inc. was Turned based in 1982 and is situated in Baton Rouge, Louisiana.